Acquire the license to the best health content in the world
Contact Us

Are U.S. Health Experts Inflating Flu Statistics?

Journal article claims they are, but CDC expert denies the charge

FRIDAY, Dec. 9, 2005 (HealthDay News) -- A Harvard grad student is charging that the U.S. government is hyping the threat of the annual (non-avian) strains of influenza. Specifically, Peter Doshi says, the estimate of 36,000 flu-related deaths a year by the Centers for Disease Control and Prevention is unsupported by the available data.

And, he suspects, the numbers may be inflated to help drug companies sell more flu vaccine.

It's a familiar charge -- a quick scan of the Internet turns up several Web sites claiming much the same thing -- and like many others who make the claim, Doshi is not a medical expert. He's a student in Harvard's department of East Asian studies.

But he presents his charges with one notable difference: They appear in the form of an article published in this week's issue of the prestigious British Medical Journal.

In his one-page article, Doshi lauded the BMJ's "system of open discussion and open debate through their on-line bulletin board ... a very democratic form of scientific discourse."

His criticism centers on a 2003 paper in the Journal of the American Medical Association in which CDC experts increased their estimate of flu-related deaths from 20,000 a year to 36,000 a year. The reasons the agency used to justify that rise are dubious at best, Doshi said.

For one thing, the National Center for Health Statistics lists only a few hundred deaths a year as directly caused by influenza, Doshi said. And the major explanation for the increased estimate -- the aging of the American population that puts more people in the highly vulnerable over-65 group -- doesn't hold water, he maintained.

"The 65-plus population grew just 12 percent between 1990 and 2000," Doshi wrote. How can the CDC justify an estimate of 36,000 U.S. deaths a year now when there were just 34,000 deaths recorded in the 1968-1969 "Hong Kong flu" epidemic? he asked.

But William W. Thompson, the CDC epidemiologist who was the lead author of the 2003 paper, said Doshi is missing the big picture.

The increase in older Americans has been substantial over the longer run -- up by 48 percent between 1976 and 1999, he said. The number of Americans in the most-vulnerable 85-and-older age group has doubled during that time, Thompson said.

That increase in the older population explains why more Americans die in an ordinary flu year nowadays than in the Hong Kong pandemic, he said. Most of them don't die directly of the flu, Thompson stressed. Instead, the immediate cause of death is often listed as pneumonia.

"Influenza is rarely reported on the death certificate, even though influenza is responsible for many deaths," Thompson said. "Pneumonia and influenza are grouped together because many pneumonias result from influenza. Influenza is listed as a secondary cause of death."

That is not how Doshi sees it. Instead, his article talks of a "public relations approach" linked to drug company profits. "CDC is already working in the manufacturers' interest by conducting campaigns to increase vaccinations," he wrote.

"I don't understand that argument," Thompson said. "We have used this method for the past 40 years, and we continue to use these estimates. We don't need drug manufacturers' approval or anything like it."

Thompson said the CDC's annual advice remains the same: "I think that people who are at high risk for flu- associated complications should get vaccinated."

Of the British Medical Journal, he said, "It surprises me that they would publish something like that without giving us a chance to reply."

Will there be a reply?

"We're considering it," Thompson said.

More information

Guidelines for the prevention and treatment of colds and the flu are available at the American Lung Association.

SOURCES: Peter Doshi, graduate student, Harvard University, Boston; William W. Thompson, Ph.D., epidemiologist, U.S. Centers for Disease Control and Prevention, Atlanta; Dec. 10, 2005, British Medical Journal
Consumer News